Researchers develop readmission rate calculator to ID high-risk patients

Researchers from the National University of Singapore (NUS) have developed a web-based calculator identifying patients at high risk for readmission to administer preventive treatment and avoid eventual readmission.

With global hospital readmission rates within 30 days being as high as 20 percent, identifying high-risk patients could improve care and control costs. The online tool, showcased in Pharmacotherapy, was tested on 621 patients to predict 15-day readmission risk by analyzing a variety of factors.

"Hospital readmissions place immense strain on the healthcare system,” said Alexandre Chan, associate professor at the NUS. “By cutting down the number of preventable readmissions, hospital-related healthcare costs can be significantly reduced. Our simple tool helps healthcare teams identify high-risk patients and facilitates the administration of targeted interventions for these patients—during admission or post-discharge—to reduce readmission rates.”

The online system analyzed factors including age, pre-existing conditions, number of discharge medications, discharge destination and evidence of premature discharge against medical advice. These factors were calculated for 15-day readmission risk and meant to be used while the patient is still in their initial hospital stay to identify early intervention treatments to avoid readmission.

Results showed that 15-day readmission risk was strongly associated with the number of discharge medications and if patients were discharged to a nursing home. For each additional medication, the likelihood of 15-day readmission increased 6 percent. Researchers hope the tool can improve use of targeted intervention programs.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”